146 related articles for article (PubMed ID: 3851698)
1. Modulation of natural killer activity by thymosin alpha 1 and interferon.
Favalli C; Jezzi T; Mastino A; Rinaldi-Garaci C; Riccardi C; Garaci E
Cancer Immunol Immunother; 1985; 20(3):189-92. PubMed ID: 3851698
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.
Favalli C; Mastino A; Jezzi T; Grelli S; Goldstein AL; Garaci E
Int J Immunopharmacol; 1989; 11(5):443-50. PubMed ID: 2807622
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.
Garaci E; Mastino A; Pica F; Favalli C
Cancer Immunol Immunother; 1990; 32(3):154-60. PubMed ID: 2126987
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
Pica F; Mastino A; Grelli S; Jezzi T; Favalli C
J Chemother; 1989 Jul; 1(4 Suppl):1167-9. PubMed ID: 16312818
[No Abstract] [Full Text] [Related]
5. Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice.
Garaci E; Mastino A; Jezzi T; Riccardi C; Favalli C
Cell Immunol; 1987 Apr; 106(1):43-52. PubMed ID: 3568147
[TBL] [Abstract][Full Text] [Related]
6. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
[TBL] [Abstract][Full Text] [Related]
7. Interaction between thymic hormones and other immunomodulatory agents.
Mastino A; Favalli C; Grelli S; Garaci E
Ann Ist Super Sanita; 1991; 27(1):51-6. PubMed ID: 1958028
[TBL] [Abstract][Full Text] [Related]
8. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
[TBL] [Abstract][Full Text] [Related]
9. Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration.
Di Francesco P; Pica F; Marini S; Favalli C; Garaci E
Int J Immunopharmacol; 1992 Jan; 14(1):1-9. PubMed ID: 1582729
[TBL] [Abstract][Full Text] [Related]
10. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immune response and antitumor immunity with combinations of biological response modifiers.
Garaci E; Mastino A; Favalli C
Bull N Y Acad Med; 1989 Jan; 65(1):111-9. PubMed ID: 2481523
[TBL] [Abstract][Full Text] [Related]
12. Increase of mouse resistance to Candida albicans infection by thymosin alpha 1.
Bistoni F; Marconi P; Frati L; Bonmassar E; Garaci E
Infect Immun; 1982 May; 36(2):609-14. PubMed ID: 7085074
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
[TBL] [Abstract][Full Text] [Related]
15. Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
Ohmori H; Kamo M; Yamakoshi K; Nitta MH; Hikida M; Kanayama N
Immunopharmacol Immunotoxicol; 2001 Feb; 23(1):75-82. PubMed ID: 11322651
[TBL] [Abstract][Full Text] [Related]
16. [Effect of thymosin alpha 1 on cellular immune function in elderly patients with malignant tumor].
Yang YM; Lu XY; Huang WD; Shen MY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):339-41. PubMed ID: 12970939
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.
Serrate SA; Schulof RS; Leondaridis L; Goldstein AL; Sztein MB
J Immunol; 1987 Oct; 139(7):2338-43. PubMed ID: 3116079
[TBL] [Abstract][Full Text] [Related]
19. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
Hirai N; Hill NO; Motoo Y; Osther K
Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
[TBL] [Abstract][Full Text] [Related]
20. Protective activity of thymosin alpha 1 against tumor progression in immunosuppressed mice.
Ishitsuka H; Umeda Y; Sakamoto A; Yagi Y
Adv Exp Med Biol; 1983; 166():89-100. PubMed ID: 6650286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
